Treatment options for metastatic hormone-sensitive prostate cancer

被引：3
|
作者：
Kostos, Louise [1 ]
Murphy, Declan G. [2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Urol, Melbourne, Vic, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 10期
关键词：
D O I：
10.1016/S1470-2045(22)00520-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1234 / 1235
页数：2
相关论文
共 50 条
  • [41] Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
    Smith, Matthew R.
    Hussain, Maha
    Saad, Fred
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Kopyltsov, Evgeny
    Park, Chandler H.
    Alekseev, Boris
    Montesa-Pino, Alvaro
    Ye, Dingwei
    Parnis, Francis
    Cruz, Felipe
    Tammela, Teuvo L. J.
    Suzuki, Hiroyoshi
    Utriainen, Tapio
    Fu, Cheng
    Uemura, Motohide
    Mendez-Vidal, Maria J.
    Maughan, Benjamin L.
    Joensuu, Heikki
    Thiele, Silke
    Li, Rui
    Kuss, Iris
    Tombal, Bertrand
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (12): : 1132 - 1142
  • [42] Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients
    Sigurdson, Samantha S.
    Vera-Badillo, Francisco E.
    de Moraes, Fabio Ynoe
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] Triplet Therapy: Entering the Metaverse of Metastatic Hormone-sensitive Prostate Cancer Treatment
    Dzimitrowicz, Hannah E.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2022, 82 (06) : 599 - 601
  • [44] The Past, Present, and Future of Treatment Intensification for Metastatic Hormone-Sensitive Prostate Cancer
    Mcmanus, Hannah D.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (20) : 3576 - +
  • [45] New treatment approaches for and ongoing trials in metastatic hormone-sensitive prostate cancer
    Isgandarov, A.
    Darr, C.
    Posdzich, P.
    Hermann, K.
    Hadaschik, B. A.
    Gruenwald, V.
    UROLOGIE, 2023, 62 (04): : 369 - 375
  • [46] Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm
    Weiner, Adam B.
    Nettey, Oluwarotimi S.
    Morgans, Alicia K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (09)
  • [47] Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer
    Tassinari, Davide
    Tamburini, Emiliano
    Gianni, Lorenzo
    Drudi, Fabrizio
    Fantini, Manuela
    Santelmo, Carlotta
    Stocchi, Lucia
    Montanari, Francesco
    Sartori, Sergio
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (04) : 317 - 323
  • [48] Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm
    Adam B. Weiner
    Oluwarotimi S. Nettey
    Alicia K. Morgans
    Current Treatment Options in Oncology, 2019, 20
  • [49] Metastatic Hormone-sensitive Prostate Cancer: Patient Selection for Prostate Radiotherapy
    Chakrabarti, Deep
    Parker, Chris C.
    EUROPEAN UROLOGY, 2024, 86 (01) : 18 - 19
  • [50] Clinical utility of intraductal carcinoma of the prostate in treatment selection for metastatic hormone-sensitive prostate cancer
    Naito, Yushi
    Kato, Masashi
    Kawanishi, Hideji
    Yamamoto, Akiyuki
    Sakamoto, Fumitoshi
    Hirabayashi, Hiroki
    Kobayashi, Masataka
    Matsukawa, Yoshihisa
    Kimura, Tohru
    Araki, Hidemori
    Nishikimi, Toshinori
    Kondo, Atsuya
    Yoshino, Yasushi
    Hashimoto, Yoshimasa
    Nakano, Yojiro
    Tsuzuki, Toyonori
    PROSTATE, 2023, 83 (04): : 307 - 315
12345